1.Mahmoudi S, Masoomi A, Ahmadikia K, Tabatabaei SA, Soleimani M, Rezaie S, et al. Fungal keratitis: An overview of clinical and laboratory aspects. Mycoses. 2018;61:916–30.
2.Rautaraya B, Sharma S, Kar S, Das S, Sahu SK. Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India. BMC ophthalmology. 2011;11:39.
3.Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian journal of ophthalmology. 2003;51:315–21.
4.Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea. 2008;27:283–7.
5.Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307–12.
6.Hassan HM, Papanikolaou T, Mariatos G, Hammad A, Hassan H. Candida albicans keratitis in an immunocompromised patient. Clinical ophthalmology (Auckland, NZ). 2010;4:1211–5.
7.Wang L, Sun S, Jing Y, Han L, Zhang H, Yue J. Spectrum of fungal keratitis in central China. Clinical & experimental ophthalmology. 2009;37:763–71.
8.Oldenburg CE, Prajna VN, Prajna L, Krishnan T, Mascarenhas J, Vaitilingam CM, et al. Clinical signs in dematiaceous and hyaline fungal keratitis. The British journal of ophthalmology. 2011;95:750–1.
9.Kalavathy CM, Parmar P, Kaliamurthy J, Philip VR, Ramalingam MD, Jesudasan CA, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea. 2005;24:449–52.
10.Warner DB, Wright IH, Rosenbaum ER. Rhizopus Keratitis Associated with Poor Contact Lens Hygiene. Case reports in ophthalmology. 2016;7:21–4.
11.Tanhehco TY, Stacy RC, Mendoza L, Durand ML, Jakobiec FA, Colby KA. Pythium insidiosum keratitis in Israel. Eye & contact lens. 2011;37:96–8.
12.Krajaejun T, Pracharktam R, Wongwaisayawan S, Rochanawutinon M, Kunakorn M, Kunavisarut S. Ocular pythiosis: is it under-diagnosed? American journal of ophthalmology. 2004;137:370–2.
13.Adler A, Yaniv I, Samra Z, Yacobovich J, Fisher S, Avrahami G, et al. Exserohilum: an emerging human pathogen. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2006;25:247–53.
14.Wang L, Al-Hatmi AM, Lai X, Peng L, Yang C, Lai H, et al. Bipolaris oryzae, a novel fungal opportunist causing keratitis. Diagnostic microbiology and infectious disease. 2016;85:61–5.
15.Shivaprakash MR, Appannanavar SB, Dhaliwal M, Gupta A, Gupta S, Gupta A, et al. Colletotrichum truncatum: an unusual pathogen causing mycotic keratitis and endophthalmitis. Journal of clinical microbiology. 2011;49:2894–8.
16.Shiraishi A, Araki-Sasaki K, Mitani A, Miyamoto H, Sunada A, Ueda A, et al. Clinical characteristics of keratitis due to Colletotrichum gloeosporioides. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2011;27:487–91.
17.Rathi H, Venugopal A, Rameshkumar G, Ramakrishnan R, Meenakshi R. Fungal Keratitis Caused by Exserohilum, An Emerging Pathogen. Cornea. 2016;35:644–6.
18.Schwartz LK, Loignon LM, Webster RG, Jr. Posttraumatic phycomycosis of the anterior segment. Archives of ophthalmology (Chicago, Ill: 1960). 1978;96:860–3.
19.Azari AA, Nehls S, Ghoghawala SY, Lee V, Kanavi MR, Potter HD. Rhizopus keratitis following corneal trauma. JAMA ophthalmology. 2013;131:776.
20.Kumar A, Khurana A, Sharma M, Chauhan L. Causative fungi and treatment outcome of dematiaceous fungal keratitis in North India. Indian journal of ophthalmology. 2019;67:1048–53.
21.Yuan X, Wilhelmus KR, Matoba AY, Alexandrakis G, Miller D, Huang AJ. Pathogenesis and outcome of Paecilomyces keratitis. American journal of ophthalmology. 2009;147:691–6.e3.
22.Luangsa-Ard J, Houbraken J, van Doorn T, Hong SB, Borman AM, Hywel-Jones NL, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS microbiology letters. 2011;321:141–9.
23.Chidambaram JD, Prajna NV, Larke N, Macleod D, Srikanthi P, Lanjewar S, et al. In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis. The British journal of ophthalmology. 2017;101:1119–23.
24.Anutarapongpan O, Thanathanee O, Worrawitchawong J, Suwan-Apichon O. Role of Confocal Microscopy in the Diagnosis of Pythium insidiosum Keratitis. Cornea. 2018;37:156–61.
25.Okhravi N, Lightman S. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2007;13:554.
26.Todokoro D, Yamada N, Fukuchi M, Kishi S. Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers. International ophthalmology. 2014;34:1159–63.
27.Agarwal S, Iyer G, Srinivasan B, Agarwal M, Panchalam Sampath Kumar S, Therese LK. Clinical profile of pythium keratitis: perioperative measures to reduce risk of recurrence. The British journal of ophthalmology. 2018;102:153–7.
28.Jesus FP, Loreto ES, Ferreiro L, Alves SH, Driemeier D, Souza SO, et al. In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. Antimicrobial agents and chemotherapy. 2016;60:87–91.
29.Chen Y, Yang W, Gao M, Belin MW, Yu H, Yu J. Experimental study on cryotherapy for fungal corneal ulcer. BMC ophthalmology. 2015;15:29.